Skip to main content

Advertisement

Log in

EPONYM

Sweet syndrome

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Sweet syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by tender, red inflammatory nodules or papules that occur in association with infection, malignancy, connective tissue disease, or following exposure to certain drugs. Although drug-induced Sweet syndrome is rare, granulocyte colony-stimulating factor, all-trans-retinoic acid, and miscellaneous drugs have been implicated in causing this disorder in adults. In pediatric patients, granulocyte colony-stimulating factor, all-trans-retinoic acid, trimethoprim-sulfamethoxazole, and azathioprine have been implicated as potential causes of drug-induced Sweet syndrome. To date, six cases, including the patient reported here, have been reported in children.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

SS:

Sweet syndrome

c-ANCA:

c-type anti-neutrophil cytoplasmic antibody

TPMT:

Thiopurine methyltransferase

GCSF:

Granulocyte colony-stimulating factor

References

  1. Abecassis S, Ingen-Housz-Oro S, Cavelier-Balloy B et al (2004) Particular histological features of a case of Sweet’s syndrome induced by G-CSF. Ann Dermatol Vénéréol 131:369–372

    Article  CAS  PubMed  Google Scholar 

  2. Aguiar-Bujanda D, Aguiar-Morales J, Bohn-Sarmiento U (2004) Sweet’s syndrome associated with norfloxacin in a prostate cancer patient. QJM 97:55–56

    Article  CAS  PubMed  Google Scholar 

  3. Ahn SJ, Choi JH, Sung KJ et al (2000) Sweet’s syndrome presenting with lesions resembling eruptive xanthoma. Br J Dermatol 143:449–450

    Article  CAS  PubMed  Google Scholar 

  4. Al-Saad K, Khanani MF, Naqvi A et al (2004) Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 26:197–199

    Article  PubMed  Google Scholar 

  5. Alvaro T, Garcia del Moral R, Gomez-Morales M et al (1991) Immunopathological studies of Sweet’s syndrome. Br J Dermatol 124:111–112

    Article  CAS  PubMed  Google Scholar 

  6. Arbetter KR, Hubbard KW, Markovic SN et al (1999) Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 61:126–129

    Article  CAS  PubMed  Google Scholar 

  7. Bianchi L, Masi M, Hagman JH et al (1999) Systemic interferon-alpha treatment for idiopathic Sweet’s syndrome. Clin Exp Dermatol 24:443–445

    Article  CAS  PubMed  Google Scholar 

  8. Bidyasar S, Montoya M, Suleman K et al (2008) Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26:4355–4356

    Article  PubMed  Google Scholar 

  9. Boatman BW, Taylor RC, Klein LE et al (1994) Sweet’s syndrome in children. South Med J 87:193–196

    Article  CAS  PubMed  Google Scholar 

  10. Christ E, Linka A, Jacky E et al (1996) Sweet’s syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia 10:731–734

    CAS  PubMed  Google Scholar 

  11. Cobb MW (1989) Furosemide-induced eruption simulating Sweet’s syndrome. J Am Acad Dermatol 21:339–343

    Article  CAS  PubMed  Google Scholar 

  12. Cohen PR (2007) Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34

    Article  PubMed  Google Scholar 

  13. Cohen PR, Almeida L, Kurzrock R (1989) Acute febrile neutrophilic dermatosis. Am Fam Physician 39:199–204

    CAS  PubMed  Google Scholar 

  14. Cohen PR, Kurzrock R (1993) Sweet’s syndrome and cancer. Clin Dermatol 11:149–157

    Article  CAS  PubMed  Google Scholar 

  15. Cohen PR, Kurzrock R (2000) Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18:265–282

    Article  CAS  PubMed  Google Scholar 

  16. Cohen PR, Kurzrock R (2003) Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 42:761–778

    Article  PubMed  Google Scholar 

  17. Cohen PR, Talpaz M, Kurzrock R (1988) Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol 6:1887–1897

    CAS  PubMed  Google Scholar 

  18. Corbett M, Schlup M (2001) Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease. Intern Med J 31:366–367

    Article  CAS  PubMed  Google Scholar 

  19. Cox NH, O’Brien HA (1994) Sweet’s syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 19:51–52

    Article  CAS  PubMed  Google Scholar 

  20. de Fonclare AL, Khosrotehrani K, Aractingi S et al (2007) Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease. Arch Dermatol 143:744–748

    Article  PubMed  Google Scholar 

  21. Del Giudice P, Vandenbos F, Perrin C et al (2004) Sweet’s syndrome following abacavir therapy. J Am Acad Dermatol 51:474–475

    Article  PubMed  Google Scholar 

  22. Dunn TR, Saperstein HW, Biederman A et al (1992) Sweet syndrome in a neonate with aseptic meningitis. Pediatr Dermatol 9:288–292

    Article  CAS  PubMed  Google Scholar 

  23. El-Azhary RA (2003) Azathioprine: current status and future considerations. Int J Dermatol 42:335–341

    Article  CAS  PubMed  Google Scholar 

  24. El-Azhary RA, Brunner KL, Gibson LE (2008) Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc 83:1026–1030

    Article  PubMed  Google Scholar 

  25. Fett DL, Gibson LE, Su WP (1995) Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 70:234–240

    Article  CAS  PubMed  Google Scholar 

  26. Fitzgerald RL, McBurney EI, Nesbitt LT Jr (1996) Sweet’s syndrome. Int J Dermatol 35:9–15

    Article  CAS  PubMed  Google Scholar 

  27. Fye KH, Crowley E, Berger TG et al (2001) Celecoxib-induced Sweet’s syndrome. J Am Acad Dermatol 45:300–302

    Article  CAS  PubMed  Google Scholar 

  28. Garey KW, Streetman DS, Rainish MC (1998) Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother 32:425–428

    Article  CAS  PubMed  Google Scholar 

  29. Garty BZ, Levy I, Nitzan M et al (1996) Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Pediatrics 97:401–403

    CAS  PubMed  Google Scholar 

  30. Gilmour E, Chalmers RJ, Rowlands DJ (1995) Drug-induced Sweet’s syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine. Br J Dermatol 133:490–491

    Article  CAS  PubMed  Google Scholar 

  31. Ginarte M, Garcia Doval I, Toribio J (1997) Sweet’s syndrome: a study of 16 cases. Med Clin (Barc) 109:588–591

    CAS  Google Scholar 

  32. Going JJ, Going SM, Myskow MW et al (1987) Sweet’s syndrome: histological and immunohistochemical study of 15 cases. J Clin Pathol 40:175–179

    Article  CAS  PubMed  Google Scholar 

  33. Gray LC, Abele DC (1998) Annular erythematous plaques and tibial pain in a child. Sweet syndrome. Arch Dermatol 134(625–626):628–629

    Google Scholar 

  34. Guimera FJ, Garcia-Bustinduy M, Noda A et al (2000) Diazepam-associated Sweet’s syndrome. Int J Dermatol 39:795–798

    Article  CAS  PubMed  Google Scholar 

  35. Gyorfy A, Kovacs T, Szegedi I et al (2003) Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol 40:135–136

    Article  PubMed  Google Scholar 

  36. Halpern J, Salim A (2009) Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol 26:452–457

    Article  PubMed  Google Scholar 

  37. Howard R, Tsuchiya A (1998) Adult skin disease in the pediatric patient. Dermatol Clin 16:593–608

    Article  CAS  PubMed  Google Scholar 

  38. Itami S, Nishioka K (1980) Sweet’s syndrome in infancy. Br J Dermatol 103:449–451

    Article  CAS  PubMed  Google Scholar 

  39. Jordaan HF (1989) Acute febrile neutrophilic dermatosis. A histopathological study of 37 patients and a review of the literature. Am J Dermatopathol 11:99–111

    Article  CAS  PubMed  Google Scholar 

  40. Klock JC, Oken RL (1976) Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 37:922–927

    Article  CAS  PubMed  Google Scholar 

  41. Knowles S, Shear NH (1997) Azathioprine hypersensitivity reactions: caution upon rechallenge. Muscle Nerve 20:1467–1468

    Article  CAS  PubMed  Google Scholar 

  42. Kumar G, Bernstein JM, Waibel JS et al (2004) Sweet’s syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol 76:283–285

    Article  PubMed  Google Scholar 

  43. Magro CM, Crowson AN (1997) A distinctive vesiculopustular eruption associated with hepatobiliary disease. Int J Dermatol 36:837–844

    Article  CAS  PubMed  Google Scholar 

  44. Majeed HA, Kalaawi M, Mohanty D et al (1989) Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 115:730–734

    Article  CAS  PubMed  Google Scholar 

  45. McGovern DP, Travis SP, Duley J et al (2002) Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology 122:838–839

    Article  CAS  PubMed  Google Scholar 

  46. McLeod HL, Krynetski EY, Relling MV et al (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14:567–572

    Article  CAS  PubMed  Google Scholar 

  47. Mensing H, Kowalzick L (1991) Acute febrile neutrophilic dermatosis (Sweet’s syndrome) caused by minocycline. Dermatologica 182:43–46

    Article  CAS  PubMed  Google Scholar 

  48. Miller RM, Darben TA, Nedwich J et al (1999) Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves’ disease and a neutrophilic dermatosis. Br J Dermatol 141:943–944

    Article  CAS  PubMed  Google Scholar 

  49. Morgan KW, Callen JP (2001) Sweet’s syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 45:590–595

    Article  CAS  PubMed  Google Scholar 

  50. Noda K, Okuma Y, Fukae J et al (2001) Sweet’s syndrome associated with encephalitis. J Neurol Sci 188:95–97

    Article  CAS  PubMed  Google Scholar 

  51. Otheo E, Ros P, Vazquez JL et al (2002) Systemic inflammatory response syndrome associated with Sweet’s syndrome. Pediatr Crit Care Med 3:190–193

    Article  PubMed  Google Scholar 

  52. Ozdemir D, Korkmaz U, Sahin I et al (2006) Ofloxacin induced Sweet’s syndrome in a patient with Crohn’s disease. J Infect 52:e155–e157

    Article  PubMed  Google Scholar 

  53. Paoluzi OA, Crispino P, Amantea A et al (2004) Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome. Case report and review of literature. Dig Liver Dis 36:361–366

    Article  CAS  PubMed  Google Scholar 

  54. Parsapour K, Reep MD, Gohar K et al (2003) Familial Sweet’s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol 49:132–138

    Article  PubMed  Google Scholar 

  55. Piette WW, Trapp JF, O’Donnell MJ et al (1994) Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 30:293–297

    Article  CAS  PubMed  Google Scholar 

  56. Retief CR, Malkinson FD (1999) Nitrofurantoin-associated Sweet’s syndrome. Cutis 63:177–179

    CAS  PubMed  Google Scholar 

  57. Sarkany RP, Burrows NP, Grant JW et al (1998) The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol 138:365–366

    Article  CAS  PubMed  Google Scholar 

  58. Saxe N, Gordon W (1978) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Four case reports. S Afr Med J 53:253–256

    CAS  PubMed  Google Scholar 

  59. Schonfeldt-Lecuona C, Connemann BJ (2002) Sweet’s syndrome and polyserositis with clozapine. Am J Psychiatry 159:1947

    Article  PubMed  Google Scholar 

  60. Shimizu T, Yoshida I, Eguchi H et al (1996) Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 18:282–284

    Article  CAS  PubMed  Google Scholar 

  61. Sinico RA, Sabadini E, Borlandelli S et al (2003) Azathioprine hypersensitivity: report of two cases and review of the literature. J Nephrol 16:272–276

    PubMed  Google Scholar 

  62. Sitjas D, Puig L, Cuatrecasas M et al (1993) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Int J Dermatol 32:261–268

    Article  CAS  PubMed  Google Scholar 

  63. Su WP, Liu HN (1986) Diagnostic criteria for Sweet’s syndrome. Cutis 37:167–174

    CAS  PubMed  Google Scholar 

  64. Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76:349–356

    Article  CAS  PubMed  Google Scholar 

  65. Tefany FJ, Georgouras K (1991) A neutrophilic reaction of Sweet’s syndrome type associated with the oral contraceptive. Australas J Dermatol 32:55–59

    Article  CAS  PubMed  Google Scholar 

  66. Thibault MJ, Billick RC, Srolovitz H (1992) Minocycline-induced Sweet’s syndrome. J Am Acad Dermatol 27:801–804

    Article  CAS  PubMed  Google Scholar 

  67. Thompson DF, Montarella KE (2007) Drug-induced Sweet’s syndrome. Ann Pharmacother 41:802–811

    Article  CAS  PubMed  Google Scholar 

  68. Thompson MA, Dyson SW, Faderl S (2006) Sweet’s syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor. Am J Hematol 81:703–705

    Article  PubMed  Google Scholar 

  69. Tomas JF, Escudero A, Fernandez-Ranada JM (1994) All-trans retinoic acid treatment and Sweet syndrome. Leukemia 8:1596

    CAS  PubMed  Google Scholar 

  70. Uhara H, Saida T, Nakazawa H et al (2008) Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor. J Am Acad Dermatol 59:S10–S12

    Article  PubMed  Google Scholar 

  71. Veres K, Haraszti A, Nemes Z et al (1999) Sweet syndrome following therapeutic use of granulocyte colony stimulating factor. Orv Hetil 140:1059–1061

    CAS  PubMed  Google Scholar 

  72. von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31:535–556, quiz 557–560

    Article  PubMed  Google Scholar 

  73. Walker DC, Cohen PR (1996) Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 34:918–923

    Article  CAS  PubMed  Google Scholar 

  74. White JM, Mufti GJ, Salisbury JR et al (2006) Cutaneous manifestations of granulocyte colony-stimulating factor. Clin Exp Dermatol 31:206–207

    Article  CAS  PubMed  Google Scholar 

  75. Yiasemides E, Thom G (2009) Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis. Australas J Dermatol 50:48–51

    Article  PubMed  Google Scholar 

  76. Ytting H, Vind I, Bang D et al (2005) Sweet’s syndrome-an extraintestinal manifestation in inflammatory bowel disease. Digestion 72:195–200

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

There was no grant support for this article.

Conflict of interests

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yon Ho Choe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, M.J., Choe, Y.H. EPONYM. Eur J Pediatr 169, 1439–1444 (2010). https://doi.org/10.1007/s00431-010-1201-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-010-1201-z

Keywords

Navigation